Clinical trial
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or…
NCT00006340 · Boston Medical Center, Other · Completed
Key facts
| NCT number | NCT00006340 |
|---|---|
| Title | Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus |
| Official title | A PHASE I TRIAL OF BUTYRATE AND GANCICLOVIR IN EBV-ASSOCIATED MALIGNANCIES |
| Lead sponsor | Boston Medical Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Precancerous Condition, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | arginine butyrate, ganciclovir |
| Start date | Dec 1, 1994 |
| Primary completion | Jul 1, 2000 |
| Completion | Jul 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 26, 2013 |
| Countries | France, Germany, Italy, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: